BRPI0909659A2 - tratamento para distúrbios relacionados oculares - Google Patents

tratamento para distúrbios relacionados oculares

Info

Publication number
BRPI0909659A2
BRPI0909659A2 BRPI0909659A BRPI0909659A BRPI0909659A2 BR PI0909659 A2 BRPI0909659 A2 BR PI0909659A2 BR PI0909659 A BRPI0909659 A BR PI0909659A BR PI0909659 A BRPI0909659 A BR PI0909659A BR PI0909659 A2 BRPI0909659 A2 BR PI0909659A2
Authority
BR
Brazil
Prior art keywords
treatment
related disorders
eye related
eye
disorders
Prior art date
Application number
BRPI0909659A
Other languages
English (en)
Portuguese (pt)
Inventor
Chang Hahn
Ellen Matzkin
Ramalinga Dharanipragada
Thomas Oligino
Timothy A Gillespy
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of BRPI0909659A2 publication Critical patent/BRPI0909659A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
BRPI0909659A 2008-03-10 2009-03-05 tratamento para distúrbios relacionados oculares BRPI0909659A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3507308P 2008-03-10 2008-03-10
PCT/US2009/036119 WO2009114373A1 (en) 2008-03-10 2009-03-05 Treatment for ocular-related disorders

Publications (1)

Publication Number Publication Date
BRPI0909659A2 true BRPI0909659A2 (pt) 2015-09-22

Family

ID=40583469

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0909659A BRPI0909659A2 (pt) 2008-03-10 2009-03-05 tratamento para distúrbios relacionados oculares

Country Status (22)

Country Link
EP (1) EP2285378A1 (ru)
JP (1) JP2011513488A (ru)
KR (1) KR20110009084A (ru)
CN (1) CN101965188A (ru)
AR (1) AR070975A1 (ru)
AU (1) AU2009223501A1 (ru)
BR (1) BRPI0909659A2 (ru)
CA (1) CA2717991A1 (ru)
CL (1) CL2009000551A1 (ru)
CO (1) CO6290691A2 (ru)
CR (1) CR11644A (ru)
DO (1) DOP2010000266A (ru)
IL (1) IL207906A0 (ru)
MA (1) MA32211B1 (ru)
MX (1) MX2010008308A (ru)
NI (1) NI201000131A (ru)
NZ (1) NZ587906A (ru)
RU (1) RU2010141560A (ru)
SV (1) SV2010003658A (ru)
TW (1) TW200950784A (ru)
WO (1) WO2009114373A1 (ru)
ZA (1) ZA201005337B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201034675A (en) 2008-12-18 2010-10-01 Sanofi Aventis Method for treating macular degeneration
EP2441755A1 (en) 2010-09-30 2012-04-18 Almirall, S.A. Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors
EP2489663A1 (en) 2011-02-16 2012-08-22 Almirall, S.A. Compounds as syk kinase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ301750B6 (cs) * 1999-12-24 2010-06-09 Aventis Pharma Limited Bicyklický pyrrolový derivát, jeho použití pri výrobe léciva, farmaceutická kompozice tento derivát obsahující a pro použití pri lécení
CA2400923A1 (en) * 2000-02-25 2001-08-30 Merck & Co., Inc. Tyrosine kinase inhibitors
KR20140025610A (ko) * 2005-09-30 2014-03-04 미카나 테라퓨틱스, 인크. 치환된 피라졸 화합물
CL2007002617A1 (es) * 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.

Also Published As

Publication number Publication date
RU2010141560A (ru) 2012-04-20
CL2009000551A1 (es) 2009-08-21
CN101965188A (zh) 2011-02-02
MX2010008308A (es) 2010-08-11
SV2010003658A (es) 2011-01-31
AR070975A1 (es) 2010-05-19
CA2717991A1 (en) 2009-09-17
ZA201005337B (en) 2011-04-28
MA32211B1 (fr) 2011-04-01
WO2009114373A1 (en) 2009-09-17
IL207906A0 (en) 2010-12-30
AU2009223501A1 (en) 2009-09-17
CR11644A (es) 2010-11-22
NI201000131A (es) 2011-09-29
JP2011513488A (ja) 2011-04-28
NZ587906A (en) 2011-12-22
KR20110009084A (ko) 2011-01-27
DOP2010000266A (es) 2010-09-30
TW200950784A (en) 2009-12-16
CO6290691A2 (es) 2011-06-20
EP2285378A1 (en) 2011-02-23

Similar Documents

Publication Publication Date Title
BRPI0919920A2 (pt) compostos para tratamento de doenças e desordens oftálmicas
HK1212883A1 (zh) 治療眼部疾病的方法
SMT201600424B (it) Emulsione oftalmica
BR112012011730A2 (pt) tratamentos para distúrbios gastrointestinais
BRPI0908260A2 (pt) Dispositivo para tratamento térmico
BRPI0911757A2 (pt) composiÇÕes e mÉtodos para tratar distérbios digestivos.
BRPI0918527A2 (pt) compostos para o tratamento de disturbios do cns
BRPI0817870A2 (pt) dispositivo para tratamento de aneurisma
BRPI1010868A2 (pt) terapia gênica para distúrbios neurodegenerativos
BRPI1013878A2 (pt) método para tratar distúrbios metabólicos, e, composto
BR112012000502A2 (pt) terapia de combinação para o tratamento de diabetes
BRPI0822849A2 (pt) Aparelho para cirurgia oftalmológica
BRPI0813670A2 (pt) Compostos para tratamento
BRPI0908715A2 (pt) métodos para tratamento da psoríase
BRPI0810071A2 (pt) Método para determinação do risco inicial de glaucoma
BRPI1009783A2 (pt) compostos para o tratamento de distúrbios metabólicos.
BRPI0919127A2 (pt) métodos para tratamento de água
BRPI0909221A2 (pt) Desordens neurodegenerativas
BRPI0917440A2 (pt) composições farmacêuticas oftálmicas para o tratamento de patologias neoangiogênicas do olho
BRPI0906606A2 (pt) Tratamento terapêutico para condições do pulmão.
BR112012006437A2 (pt) composições e métodos para tratamento do diabetes e outros distúrbios
BRPI0810091A2 (pt) Agentes fugicidas tópicos para tratar distúrbios ungueais
BRPI0812040A2 (pt) Indicações para terapia de anti-il-i-beta
BRPI0924107A2 (pt) inibidores de hsp90 para tratamento terapêutico
BRPI0812034A2 (pt) Combinações de neramexano para o tratamento de distúrbios neurodegenerativos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.